[Translated article] Recommendations on the Clinical Management of Androgenetic Alopecia: A Consensus Statement From the Spanish Hair Disorders Group of the Spanish Academy of Dermatology and Venererology (AEDV)
Authors:
Open Access
- 7 February 2024
- journal article
- research article
- Published by Elsevier in Actas Dermo-Sifiliograficas
- Vol. 115 (4) , T347-T355
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Pediatric androgenetic alopecia: A reviewJournal of the American Academy of Dermatology, 2021
- Uso de la espironolactona en dermatología: acné, hidradenitis supurativa, alopecia femenina e hirsutismoActas Dermo-Sifiliograficas, 2020
- Minoxidil 1 mg oral versus minoxidil 5% topical solution for the treatment of female-pattern hair loss: A randomized clinical trialJournal of the American Academy of Dermatology, 2020
- Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopeciaJournal of the American Academy of Dermatology, 2019
- Platelet-rich plasma for androgenetic alopecia: A review of the literature and proposed treatment protocolInternational Journal of Women's Dermatology, 2019
- Androgenetic Alopecia: An Update of Treatment OptionsDrugs, 2016
- Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know?Reviews in Endocrine and Metabolic Disorders, 2015
- A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopeciaJournal of the American Academy of Dermatology, 2014
- Hair Transplantation UpdateDermatologic Clinics, 2013
- The importance of dual 5α-reductase inhibition in the treatment of male pattern hair loss: Results of a randomized placebo-controlled study of dutasteride versus finasterideJournal of the American Academy of Dermatology, 2006